Skip to main content
Clinical Trials/NCT06553066
NCT06553066
Not yet recruiting
Not Applicable

Deep Versus Moderate Neuromuscular Blockade in Bariatric Surgery:

University Hospital of Patras0 sites50 target enrollmentAugust 2024

Overview

Phase
Not Applicable
Intervention
Deep neuromascular blockage
Conditions
Neuromuscular Blockade
Sponsor
University Hospital of Patras
Enrollment
50
Primary Endpoint
impact of a deep neuromuscular blockade on surgical conditions
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

The aim of this study is to investigate the effect of depth of neuromuscular blockade on the surgical field, patient postoperative pain, intestinal motility, the incidence of postoperative nausea and vomiting and the effect of deep versus moderate neuromuscular blockade on postoperative atelectasis quantitatively using chest computed tomography.This is a prospective, randomized, controlled clinical-controlled study in patients ≥18 years old scheduled to undergo elective bariatric surgery.

Registry
clinicaltrials.gov
Start Date
August 2024
End Date
August 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital of Patras
Responsible Party
Principal Investigator
Principal Investigator

Nikolas Drakos

MD

University Hospital of Patras

Eligibility Criteria

Inclusion Criteria

  • Patients aged ≥18 years ASA II-III who are to undergo planned laparoscopic bariatric surgery

Exclusion Criteria

  • ASA 4 patients
  • Maternal population
  • Patients who are not scheduled to receive general anesthesia, but some other type of anesthesia.
  • Contraindicated patients: administration of neuromuscular blockade, suppression of spontaneous respiration, and those with an indication for awake intubation or surgical airway.
  • Patients with neuromuscular diseases
  • Patients who refuse to participate in the study.

Arms & Interventions

Group DNMB ( Deep neuromascular blockage)

Deep Neuromuscular Block group Intervention: maintenance of a deep neuromuscular block with rocuronium, titrated to maintain a TOF count of 0, and a PTC between 1-2. Quality of surgical field conditions' assessed by a blind surgeon as a 5 points scale(Leiden scale : 1 indicates extremely poor conditions, 2 poor conditions, 3 acceptable conditions, 4, good conditions and 5 optimal conditions)

Intervention: Deep neuromascular blockage

Group DNMB ( Deep neuromascular blockage)

Deep Neuromuscular Block group Intervention: maintenance of a deep neuromuscular block with rocuronium, titrated to maintain a TOF count of 0, and a PTC between 1-2. Quality of surgical field conditions' assessed by a blind surgeon as a 5 points scale(Leiden scale : 1 indicates extremely poor conditions, 2 poor conditions, 3 acceptable conditions, 4, good conditions and 5 optimal conditions)

Intervention: Moderate neuromascular blockage

Group MNMB ( Moderate neuromascular blockage)

Moderate Neuromuscular Block group Intervention: maintenance of a moderate neuromuscular block with rocuronium, titrated to obtain a TOF count of 1-3. Quality of surgical field conditions' assessed by a blind surgeon as a 5 points scale(Leiden scale : 1 indicates extremely poor conditions, 2 poor conditions, 3 acceptable conditions, 4, good conditions and 5 optimal conditions)

Intervention: Deep neuromascular blockage

Group MNMB ( Moderate neuromascular blockage)

Moderate Neuromuscular Block group Intervention: maintenance of a moderate neuromuscular block with rocuronium, titrated to obtain a TOF count of 1-3. Quality of surgical field conditions' assessed by a blind surgeon as a 5 points scale(Leiden scale : 1 indicates extremely poor conditions, 2 poor conditions, 3 acceptable conditions, 4, good conditions and 5 optimal conditions)

Intervention: Moderate neuromascular blockage

Outcomes

Primary Outcomes

impact of a deep neuromuscular blockade on surgical conditions

Time Frame: During surgery

impact of a deep neuromuscular blockade (TOF count = 0 and posttetanic count \[PTC\] 1-2) and a moderate neuromuscular blockade (TOF count= 1 - 3) on intraoperative surgical conditions assessed by the surgeon as a 5 points scale

Secondary Outcomes

  • Mean arterial pressure (mmHg)(intraoperative and in Postanesthesia care unit)
  • Postoperative nausea and vomiting (PONV)(until first postoperative day)
  • cumulative analgetid dose (mg)(until 2 PM the next day of the surgery)
  • PIPcmH20 ( Peak inspiratory pressure)(intraoperative)
  • the effect of deep versus moderate neuromuscular blockade on postoperative atelectasis quantitatively using chest computed tomography.(in the first six postoperative hours)
  • Postoperative pain(first postoperative day)
  • Hospitalization time ( days)(up to 2 weeks)
  • PEEP cmH20(Intraoperative)
  • duration of surgery (hr)(intrapostoperative)
  • oxygen saturation (SpO2) %(intraoperative and in Postanesthesia care unit)
  • DP cmH20( Driving pressure)(Intraoperative)
  • The first flatus time (min)(up to 5 days)
  • duration of anesthesia time (min)(intraoperative)
  • Pplat cmH20 ( plateau pressure),(Intraoperative)
  • tidal volume (ml)(Intraoperative)
  • dynamic compliance ml/cmH20,(Intraoperative)
  • Resistance cmH20/L/sec(Intraoperative)

Similar Trials